Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Striatal neuron dysfunction in C9ORF72-FTD/ALS is driven by AIS and potassium channel dysregulation.

Cell reports·2026
Same author

Chitosan or ε-polylysine-functionalized mucoadhesive liposomes for enhanced intracellular delivery of Isoniazid.

International journal of biological macromolecules·2026
Same author

Preclinical evaluation of INS1201 AAV9-micro-dystrophin via CSF administration as a potential therapy for Duchenne muscular dystrophy.

Molecular therapy. Advances·2026
Same author

Brain-Targeted Delivery of Phenformin Using Phospholipid and Non-Phospholipid Vesicles for SHH Medulloblastoma.

Nanomaterials (Basel, Switzerland)·2026
Same author

Comparison of AAV9-driven motor neuron transduction following different CNS-directed delivery methods in mice.

Scientific reports·2026
Same author

Biophysical Features of Outer Membrane Vesicles (OMVs) from Pathogenic <i>Escherichia coli</i>: Methodological Implications for Reproducible OMV Characterization.

Antibiotics (Basel, Switzerland)·2026

Related Experiment Video

Updated: Mar 10, 2026

Eye-Tracking Control to Assess Cognitive Functions in Patients with Amyotrophic Lateral Sclerosis
07:00

Eye-Tracking Control to Assess Cognitive Functions in Patients with Amyotrophic Lateral Sclerosis

Published on: October 13, 2016

8.8K

High content analysis in amyotrophic lateral sclerosis.

Federica Rinaldi1, Dario Motti1, Laura Ferraiuolo2

  • 1Center for Gene Therapy, Nationwide Children's Hospital, Columbus, OH, USA.

Molecular and Cellular Neurosciences
|December 15, 2016
PubMed
Summary

Amyotrophic lateral sclerosis (ALS) research is advancing with patient-derived stem cell models and high content analysis (HCA). These tools offer new ways to understand ALS and discover potential therapies for motor neuron disease.

Keywords:
Amyotrophic lateral sclerosisAstrocytesCo-culturesHigh content screeningMotor neuronsNeurodegeneration

More Related Videos

Assay Development for High Content Quantification of Sod1 Mutant Protein Aggregate Formation in Living Cells
11:12

Assay Development for High Content Quantification of Sod1 Mutant Protein Aggregate Formation in Living Cells

Published on: October 4, 2017

7.7K
Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis
08:16

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis

Published on: March 4, 2014

33.4K

Related Experiment Videos

Last Updated: Mar 10, 2026

Eye-Tracking Control to Assess Cognitive Functions in Patients with Amyotrophic Lateral Sclerosis
07:00

Eye-Tracking Control to Assess Cognitive Functions in Patients with Amyotrophic Lateral Sclerosis

Published on: October 13, 2016

8.8K
Assay Development for High Content Quantification of Sod1 Mutant Protein Aggregate Formation in Living Cells
11:12

Assay Development for High Content Quantification of Sod1 Mutant Protein Aggregate Formation in Living Cells

Published on: October 4, 2017

7.7K
Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis
08:16

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis

Published on: March 4, 2014

33.4K

Area of Science:

  • Neuroscience
  • Cell Biology
  • Genetics

Background:

  • Amyotrophic lateral sclerosis (ALS) is a progressive motor neuron disease with limited treatment options.
  • Understanding ALS molecular mechanisms is crucial due to its devastating prognosis.
  • Current research relies on animal models, necessitating more patient-relevant approaches.

Purpose of the Study:

  • To summarize the molecular and cellular hallmarks of ALS.
  • To describe advancements in in vitro models for ALS research.
  • To review the application of high content analysis (HCA) in ALS studies.

Main Methods:

  • Utilizing patient-derived cells and stem cell technology for in vitro modeling.
  • Applying high content analysis (HCA) for automated image acquisition and digital analysis.
  • Investigating cellular morphology and survival under drug compound stimulation.

Main Results:

  • Patient-derived in vitro models offer enhanced relevance for studying ALS.
  • High content analysis (HCA) enables rapid screening of numerous compounds.
  • HCA facilitates the observation of cellular changes in response to potential therapeutics.

Conclusions:

  • Patient-derived stem cell models represent a significant advancement in ALS research.
  • High content analysis (HCA) accelerates the identification of potential ALS therapeutic targets.
  • Integrated approaches using in vitro models and HCA hold promise for developing new ALS treatments.